Thoughts On A Post-Merger Bristol-Myers Squibb: Scaling From Celgene To Buy BMSSeeking Alpha • 03/31/19
Celgene's stock surges, after Starboard withdraws proxy fight of Bristol-Myers buyout dealMarket Watch • 03/29/19
Celgene shares pop after top proxy advisor ISS recommends Bristol-Myers investors approve buyout bidCNBC • 03/29/19
Key Celgene Issue That Could 'Unnerve' Bristol Takeover Was Just TossedInvestors Business Daily • 03/14/19